The Federal Trade Commission issued civil subpoenas to Johnson and Johnson in Ju...
WASHINGTON - The Federal Trade Commission issued civil subpoenas to Johnson and Johnson in June as part of an investigation into whether contracting practices for its blockbuster rheumatoid arthritis drug, Remicade, violated antitrust laws, the company said in a regulatory filing on Monday.
Pfizer Inc filed a lawsuit against J&J in 2017, saying its rival’s contracts with health insurers for blockbuster rheumatoid arthritis drug, Remicade, were anticompetitive and aimed at blocking sales of Pfizer’s biosimilar called Inflectra. Remicade is an infused treatment for chronic autoimmune disorders and costs about $4,000 per dose, or $26,000 a year, Pfizer said in the lawsuit.Pfizer said in a statement that it had received a CID in June.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Park Rangers Lance Old Faithful In Effort To Pop Clogged, Inflamed GeyserThe Onion brings you all of the latest news, stories, photos, videos and more from America's finest news source.
Consulte Mais informação »
The many state election systems complicate efforts to stop hackersThe Senate Intelligence Committee's report notes that Russian agents “exploited the seams” between federal government expertise and ill-equipped state and local election officials.
Consulte Mais informação »
The Best Antioxidant Face Serums To Protect Your Beautiful FaceThe more antioxidants in your life—and your skincare routine—the better.
Consulte Mais informação »